Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
SAR 56.23
SAR 5060.42SAR 56.23
SAR 674.37
60 tablet
Free AirMail shipping Hot
SAR 59.97
SAR 3598.47SAR 59.97
SAR 224.73
30 tablet
Free AirMail shipping Hot
SAR 63.72
SAR 1911.60SAR 63.72
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
SAR 67.47
SAR 6072.54SAR 67.47
SAR 337.00
60 tablet
Free AirMail shipping Hot
SAR 69.35
SAR 4160.76SAR 69.35
SAR 112.27
30 tablet
Free AirMail shipping Hot
SAR 71.22
SAR 2136.51SAR 71.22
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
SAR 80.59
SAR 7253.35SAR 80.59
SAR 337.00
60 tablet
Free AirMail shipping Hot
SAR 82.47
SAR 4947.96SAR 82.47
SAR 112.27
30 tablet
Free AirMail shipping Hot
SAR 84.34
SAR 2530.12SAR 84.34
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.